Myopic and Glaucomatous optic neuropathy changes using swept source OCT
- Conditions
- Glaucoma
- Registration Number
- JPRN-UMIN000024047
- Lead Sponsor
- Topcon Corporation
- Brief Summary
It will be analyzing after add about 130 participants. Number of analyzed participants : 328 Reporting about partial results at academic conference started. Example of secondary analysis results: https://doi.org/10.1016/j.ajo.2023.01.003
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 373
Not provided
Normal persons: 1.Family history of glaucoma 2.Subjects unable to tolerate ophthalmic imaging 3.Subject with ocular media not sufficiently clear to obtain acceptable OCT images 4.HFA visual field (24-2 Sita Standard, white on white) result abnormal, defined as GHT 'Outside Normal Limits' and/or PSD < 1%, unless due to an enlarged blind spot. 5.HFA visual field (24-2 Sita Standard, white on white) result unreliable (based on manufacturer's recommendation), defined as fixation losses > 20% or false positives > 15% 6.Presence of any ocular pathology or suggestive pathologic observation 7.Previous cataract surgery or refractive surgery, Pseudophakic or aphakic 8.Narrow angle with Shaffer grade 2 or less 9.History of diabetes, leukemia, dementia or multiple sclerosis (disease that produces defect of retinal nerve) 10.History of whole body dosing of steroid or/and anticancer agent 11.Subjects with hypertension/hypotension Glaucoma patients: 1.Subjects unable to tolerate ophthalmic imaging 2.Subject with ocular media not sufficiently clear to obtain acceptable OCT images 3.HFA visual field (24-2 Sita Standard, white on white) result unreliable, defined as fixation losses > 20% or false positives > 15% 4.Presence of any ocular pathology other than glaucoma, or suggestive pathologic observation 5.Previous ocular surgery or laser treatment 6.History of diabetes, leukemia, dementia or multiple sclerosis (disease that produces defect of retinal nerve) 7.History of whole body dosing of steroid or/and anticancer agent 8.Subjects with hypertension/hypotension 9.Narrow angle with Shaffer grade 2 or less 10.Pseudophakic or aphakic
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method